Cibc World Market Inc. trimmed its holdings in Neogen Corporation (NASDAQ:NEOG – Free Report) by 19.4% in the third quarter, Holdings Channel reports. The institutional investor owned 2,821,900 shares of the company’s stock after selling 678,600 shares during the period. Cibc World Market Inc.’s holdings in Neogen were worth $36,120,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Canton Hathaway LLC acquired a new position in shares of Neogen during the 3rd quarter worth $26,000. Parallel Advisors LLC boosted its stake in Neogen by 121.8% in the third quarter. Parallel Advisors LLC now owns 2,085 shares of the company’s stock valued at $27,000 after buying an additional 1,145 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Neogen by 76.1% in the third quarter. Farther Finance Advisors LLC now owns 2,184 shares of the company’s stock valued at $28,000 after buying an additional 944 shares in the last quarter. Nykredit A S acquired a new stake in Neogen in the second quarter valued at about $28,000. Finally, Public Employees Retirement System of Ohio bought a new position in Neogen in the second quarter valued at about $34,000. 96.73% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Neogen in a report on Wednesday, November 4th. Guggenheim reaffirmed a “buy” rating and set a $14.00 price target (up from $12.00) on shares of Neogen in a report on Wednesday, September 30th. Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $13.00 to $14.00 in a research report on Wednesday, August 26th. Finally, Wall Street Zen upgraded shares of Neogen from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 14th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $12.67.
Read Our Latest Stock Report on Neogen
Neogen Stock Performance
Shares of NEOG stock opened at $11.08 on Thursday. The stock has a market capitalization of $2.42 billion, a PE ratio of -44.32, a PEG ratio of 3.89 and a beta of 1.86. The business’s 50 day simple moving average is $12.18 and its 200 day simple moving average is $10.53. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.90 and a quick ratio of 2.92. Neogen Corporation has a one year low of $5.37 and a one year high of $14.26.
Neogen (NASDAQ:NEOG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. The firm had revenue of $222.80 million for the quarter, compared to the consensus estimate of $208.18 million. Neogen had a negative net margin of 6.35% and a positive return on equity of 3.29%. The company’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.04 EPS. As a group, research analysts forecast that Neogen Corporation will post 0.28 earnings per share for the current year.
Neogen Company Profile
Neogen Corporation develops and markets products and services focused on food and animal safety. Its offerings help food producers, processors, laboratories and livestock producers detect risks, support animal health and meet safety and quality requirements. Neogen’s food safety products include tests for foodborne pathogens, allergens, toxins and sanitation indicators, as well as related laboratory supplies and services. Its animal safety offerings include veterinary instruments, animal health products, biosecurity solutions and genetic testing services for livestock.
Further Reading
- Five stocks we like better than Neogen
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
